Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD

NCT00562497 is registered in ClinicalTrials.gov with Mesoblast, Inc. as lead sponsor.

NCT NCT00562497
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00562497 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Prochymal® Infusion in Combination With Corticosteroids for the Treatment of Newly Diagnosed Acute GVHD
Lead sponsor
Mesoblast, Inc.
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2008
Completion date
May 20, 2010
Enrollment
192 (actual)
Sites
53

Conditions

As the registry lists them; a condition with its own page is linked.

graft versus host disease